Sleep Apnea Syndromes Clinical Trial
Official title:
New Out-of-center Paradigms to Simplify Sleep Apnea Diagnosis. Design and Development of an Automated Screening Test Based on Oximetry (ScreenOX)
The sleep apnea-hypopnea syndrome (SAHS) is a respiratory disorder characterized by frequent breathing cessations (apneas) or partial collapses (hypopneas) during sleep. SAHS is linked with the most important causes of death in adults from industrialized countries. Metabolic deregulation and cardiovascular and cerebrovascular diseases, such as atrial fibrillation, stroke, myocardial infarction and sudden cardiac death, could affect people having untreated SAHS. The gold standard method for SAHS diagnosis is in-hospital, technician-attended nocturnal polysomnography (PSG). Nevertheless, this methodology is labor-intensive, time-consuming, and relatively unavailable, especially in low-resource settings. These drawbacks have led to large waiting lists, which delay diagnosis and treatment and limits its effectiveness as single diagnostic method for SAHS. Blood oxygen saturation (SpO2) and pulse rate (PR) from nocturnal pulse oximetry (NPO) provide relevant and essential information to detect apneas. In addition, it is significantly less intrusive for patients and it can be easily recorded at patients' home. In the same way, automated signal processing and pattern recognition techniques have demonstrated to provide accurate tools able to detect and effectively use this information. Therefore, the investigators hypothesize that automated pattern recognition of at-home NPO recordings could provide reliable and efficient tools able to simplify the management of SAHS. The aim of this study is two-fold: 1) to prospectively assess the reliability and effectiveness of at-home NPO in the context of adult SAHS; 2) to design, optimize and extensively assess the diagnostic performance of automated NPO-based screening tools for SAHS. In order to achieve these goals, both PSG and NPO recordings are carried out ambulatory and simultaneously at patient's home. A portable polysomnograph (Embletta MPR, Natus) is used for standard PSG at home, whereas a portable wrist-worn pulse oximeter (WristOX2 3150, Nonin) is used for ambulatory NPO. In addition, conventional in-lab PSG and attended pulse oximetry are also performed simultaneously in the hospital facilities.
Participants are recruited from the specialized sleep outpatient facilities of the Río
Hortega University Hospital from Valladolid (Spain). All patients are referred from primary
care due to moderate-to-high clinical suspicion of suffering from sleep apnea-hypopnea
syndrome (SAHS). The final population is randomly split into two independent datasets: 1)
training set (50%), which is used to design and build/train the screening algorithms; and 2)
the test set (remaining 50%), which is used to further assess performance using unseen data.
The American Academy of Sleep Medicine rules are used to score respiratory events and to
obtain the apnea-hypopnea index (AHI) from ambulatory PSG at home, which is used to
definitively diagnose SAHS.
A portable wrist-worn pulse oximeter (WristOX2 3150, Nonin) is used for at-home NPO. Portable
NPO is carried out simultaneously to ambulatory PSG (Embletta MPR, Natus) at patient's home.
In addition, attended portable in-lab NPO (WristOX2 3150, Nonin) and in-lab PSG (E-Series,
Compumedics) are performed simultaneously in the hospital in a different consecutive/previous
night for comparison purposes. Participants are randomly assigned to carry out unattended
sleep studies at home before or after in-hospital recordings.
SpO2 and PR from NPO are recorded simultaneously at a sampling rate of 1 Hz (1 sample every
second). All recordings are saved to separate files and processed offline. An automatic
signal pre-processing stage is carried out to remove artifacts due to patient movements
(signal loss).
The signal processing methodology is divided into three automated stages: (i) feature
extraction, (ii) feature selection, and (iii) pattern recognition.
Firstly, NPO recordings are parameterized by means of a wide set of variables, which
previously demonstrated a high discriminative power in the context of SAHS detection. All
features are computed for each whole portable overnight recording. The following feature
subsets are composed:
- Time domain statistics from SpO2 recordings. First to fourth-order statistical moments
in the time domain, i.e., arithmetic mean, variance, skewness and kurtosis, which
quantify central tendency, amount of dispersion, asymmetry, and peakedness,
respectively.
- Time domain features from PR recordings: average, standard deviation, and root mean
square of standard deviation of the pulse-to-pulse interval time series.
- Frequency domain statistics from SpO2 recordings. First to fourth-order statistical
moments, median frequency, and Shannon spectral entropy from the power spectral density
function.
- Frequency domain statistics from PR recordings. First to fourth-order statistical
moments, median frequency, and Shannon spectral entropy from the power spectral density
function.
- Conventional spectral measures from SpO2 recordings. Total signal power as well as peak
amplitude and relative power in the frequency range 0.014 - 0.033 Hz.
- Conventional spectral measures from PR recordings. Normalized power in the low (0.04 -
0.15 Hz) and in the high (0.15 - 0.40 Hz) frequency bands, as well as the low frequency
to high frequency ratio (sympathovagal balance).
- Nonlinear features from SpO2 recordings. Sample entropy, central tendency measure, and
Lempel - Ziv complexity, which measure irregularity, variability, and complexity of SpO2
recordings.
- Nonlinear features from PR recordings. Sample entropy, central tendency measure, and
Lempel - Ziv complexity, which measure irregularity, variability, and complexity of PR
recordings.
Then, the optimum feature subset composed of the most relevant as well as complementary
variables are composed. In order to achieve this goal, the following feature selection
methods are applied:
- Forward stepwise feature selection
- Genetic algorithms
- Fast correlation-based filter
- Minimal-redundancy maximal-relevance criterion
Finally, the third stage corresponds to patter recognition. The aim of this stage is
two-fold: (i) to design and optimize binary classification-oriented models trained to discern
between SAHS negative and SAHS positive subjects using optimum features from NPO; (ii) to
design and optimize regression-oriented models trained to estimate the AHI using optimum
features from NPO. In order to achieve this goal, the following pattern recognition
algorithms are assessed:
- Binary classification: logistic regression, artificial neural networks, Bayesian
networks, decision trees, ensemble learning (AdaBoost).
- Regression models: multiple linear regression, artificial neural networks, Bayesian
networks, ensemble learning (least squares boosting).
These models are subsequently combined to optimize the following 2-stage screening protocol:
stage-1) true negative screening stage, which is aimed at detecting the maximum number of
non-SAHS subjects while minimizing the number of false negative patients (ideally 0% false
positive rate); stage-2) true positive screening stage, which is aimed at detecting (among
patients not identified as true negative in the first stage) the maximum number of true
positive patients while minimizing the number of false positive cases (ideally 0% false
positive rate). Both stages are complementary and they are implemented consecutively, such
that:
- Patients identified as true negative in the first stage are referred to the sleep
specialist to finally discard SAHS taken into account symptoms, comorbidities and past
clinical history. These patients are no longer derived to the sleep unit unless
requested by the sleep specialist due to persistent and/or additional symptoms.
- Patients identified as true positive in the second stage are referred to the sleep
specialist to finally confirm SAHS and decide the most suitable treatment option. These
patients are no longer derived to the sleep unit unless requested by the sleep
specialist.
- Non-conclusive cases are finally derived to the sleep unit for a standard PSG in order
to confirm/discard SAHS.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05477719 -
Effect of Compression Stockings on the Number of Apneas/Hypopneas Per Hour of Sleep in Patients With Syndrome Obstructive Sleep Apnea/Hypopnea as Compared to no Treatment
|
N/A | |
Completed |
NCT04979234 -
A Single Centre, Prospective Feasibility Study to Evaluate the Efficacy of an Endoluminal-suturing Device (Endomina) on Severe Obstructive Sleep Apnea Syndrome
|
N/A | |
Terminated |
NCT02735694 -
Cycloserine in the Treatment of Sleep Apnea
|
Phase 1 | |
Active, not recruiting |
NCT02470182 -
Screening for Sleep Disordered Breathing With Minimally Obtrusive Sensors
|
||
Completed |
NCT02088723 -
Testing the Elevation as Sleep Apnea Treatment
|
N/A | |
Completed |
NCT01457014 -
Sleep Disordered Breathing and Chronic Pain
|
N/A | |
Completed |
NCT00976417 -
Mechanisms of Action of Adaptive Servoventilation
|
N/A | |
Completed |
NCT00860743 -
Respiratory and Autonomic Plasticity Following Intermittent Hypoxia
|
Early Phase 1 | |
Active, not recruiting |
NCT00371293 -
The Effects of Obesity and Obstructive Sleep Apnea on Inflammation and Heart Disease
|
N/A | |
Completed |
NCT00607893 -
Efficacy of Continuous Positive Airway Pressure in Reducing Oxidative Stress in Individuals With Sleep Apnea
|
N/A | |
Completed |
NCT00083798 -
Family Linkage Study of Obstructive Sleep Apnea (OSA) in Iceland
|
N/A | |
Completed |
NCT00070681 -
Outcomes of Sleep Disorders in Older Men
|
Phase 3 | |
Completed |
NCT00089752 -
Continuous Positive Airway Pressure to Improve Milder Obstructive Sleep Apnea
|
N/A | |
Completed |
NCT00046670 -
Sleep Disordered Breathing, APOE, and Lipid Metabolism
|
N/A | |
Completed |
NCT00051363 -
Apnea Positive Pressure Long-Term Efficacy Study
|
Phase 3 | |
Completed |
NCT00031239 -
Sleep Apnea in Look AHEAD Participants - Ancillary to Look AHEAD
|
N/A | |
Completed |
NCT00006323 -
Neurobehavioral Consequences of Sleep Apnea in Children
|
N/A | |
Terminated |
NCT00006321 -
Neurocognitive Function in Snoring Children
|
N/A | |
Completed |
NCT00005511 -
SCOR in Neurobiology of Sleep--Intermediate Traits for Sleep Apnea
|
N/A | |
Completed |
NCT00005275 -
Sleep Heart Health Study (SHHS) Data Coordinating Center
|
N/A |